Analysis of Polysaccharide Hemostatic System market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031. The market is expected to witness growth owing to rising public awareness about minimally invasive surgeries, growing focus on blood loss management during surgical procedures and rising number of chronic diseases.
Also, advanced technological innovations in the healthcare industry, increasing R&D activities initiated by the private organizations and government are factors driving the development of the market.
The rise in need for bleeding control management is one of the major factors driving the market. On account of the major rise in the pervasiveness of chronic disorders, fatal injuries, cesarean deliveries and major organ surgeries, there has been rise in demand for Polysaccharide Hemostatic System.
This system helps in prevention of blood loss during surgeries, particularly for sensitive and nonanatomic structures, and among patients suffering from hemostatic abnormalities. In addition to this, their use helps in reducing the expense of the surgery, which has led their increased adoption among healthcare providers. This is boosting the polysaccharide hemostatic system market.
The US Polysaccharide Hemostatic System market is expected to observe a robust growth in the market owing to strong surgical procedures and rapid adoption of advanced technology.
The number of reconstructive surgeries, especially tumor removal, has consistently been rising. As per the American Society of Plastic Surgeons (ASPS), around 4.5 million tumor removal surgeries were carried out in 2018 in the US.
The rising obesity epidemic in the US, is also driving the market. As stated in the annual report published by the United Health Foundation, there had been a remarkable rise in the obesity rate in the U.S. by 5%. The obesity rate was reported to be 29.9% in 2017, which was observed to increase to 31.3% in 2018. The geriatric people needs critical care and are very well versed with surgeries.
This population requires large number orthopedic surgeries due to a decrease in bone density. This leads to rise in need for bleeding management during procedure to prevent blood loss. This is, in turn driving the market in US.
Europe has the second biggest region market share for hemostats. Some reasons can be attributed to this growth of the market. With rising cases of chronic conditions, the number of surgeries is also expected to rise, where the use of the hemostat system are expected to lower the risk of blood loss. Also, rising number of road accidents is leading to rise in need of bleeding control, which in turn is developing the market.
Germany holds the largest market for polysaccharide hemostatic system as the country has seen a significant rise in its geriatric population and also there has been the launch of new products. The launch of these products will drive the growth of the market if these products are used for multiple conditions.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Some of the leading manufacturers and suppliers of Polysaccharide Hemostatic System include
The Polysaccharide Hemostatic System market is a consolidated market, with the presence of a few of players available in global market. Technology partnerships and collaborations by the major players in the market with a view to bridge the demand-supply gap is expected to play a key role in development of the market. In addition, rising adoption of technologically developed surgical products to stop surgical hemorrhage is anticipated to create lucrative opportunities for the manufacturers in the market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesPre Book
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
The market is set to grow as a result of rising public awareness about minimally invasive surgeries, a greater emphasis on blood loss management during surgeries, & a rise in the number of chronic diseases.
Starch Medical Inc., Medical Expo, Medical Devices Business Services Inc., CryoLife Inc., EndoClot Plus Inc. are the top players in the Polysaccharide Hemostatic System market.
Because of strong surgeries and rapid adoption of cutting-edge technology, the US Polysaccharide Hemostatic System market is expected to have the largest market share.
The polysaccharide hemostatic system market is likely to be worth US$ 2.86 Billion in 2022.
The polysaccharide hemostatic system market has high growth potential due to a greater number of organ surgeries and the preference for minimally invasive techniques.
The manufacturers in the polysaccharide hemostatic system industry are likely to find the most opportunities in the North American region.
Need An Exclusive Report For Your Unique Requirement?